Sofinnova Crossover I SLP 13D and 13G filings for ABIVAX SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:19 pm Purchase | 2025-02-14 | 13D | ABIVAX SA ABVX | Sofinnova Crossover I SLP | 7,794,478 11.000% | 845,865 (+12.17%) | Filing |
| 2023-10-30 1:42 pm Purchase | 2023-10-20 | 13D | ABIVAX SA ABVX | Sofinnova Crossover I SLP | 6,948,613 8.000% | 6,948,613 (New Position) | Filing |